CHN2

CHN2 encodes β2-chimerin and is expressed in insulin-sensitive tissues such as adipose, where it has been implicated as a component of proximal insulin signaling in vivo (PMID:19720790). Heterozygous disruption of CHN2 by a chromosomal translocation reduces CHN2 expression in patient-derived adipose tissue, linking gene dosage to an insulin resistance/growth phenotype (PMID:19720790). Beyond this single translocation-based association (PMID:19720790), no further mechanistic detail — including the molecular activity of the β2-chimerin protein or the signaling steps it participates in — has been characterized in the available corpus.

1. 2009 Medium

   Established that CHN2 is expressed in insulin-sensitive tissue and that reducing its dosage perturbs metabolic physiology, raising it from an uncharacterized locus to a candidate component of insulin signaling.

   Evidence FISH breakpoint mapping of a t(7;19) translocation, sequencing of disrupted genes, and expression analysis in patient-derived adipose tissue

   PMID:19720790

   Open questions at the time

   • Single translocation case from one lab; association not genetically replicated
   • No in vitro reconstitution of any signaling pathway
   • Molecular activity of the β2-chimerin protein and its direct partners not defined

• How the β2-chimerin protein acts biochemically within insulin signaling, and which direct partners or substrates it engages, remains unresolved in the available corpus.
• No direct biochemical activity demonstrated in the timeline
• No physical interaction partners identified
• No causal mechanism linking CHN2 dosage to insulin resistance established